Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL505P (RNA, 7SL, cytoplasmic 505, pseudogene) is a **pseudogene** of the 7SL RNA family, which originally encodes a non-coding RNA component of the signal recognition particle (SRP) involved in cytoplasmic protein targeting and translation regulation[1][6]. The majority of 7SL-like sequences in the human genome are pseudogenes, derived from the reverse transcription of 7SL RNA back into the genome[5]. RN7SL505P is one such truncated, non-functional copy and does not encode a functional RNA or protein product, nor is it known to serve as a direct therapeutic, diagnostic, or research target[5][6]. There is no evidence that RN7SL505P plays a role in disease, drug interaction, or cellular biology, and it lacks canonical biological activity. By convention, pseudogenes are not considered classical molecular targets for drug development, but they can occasionally play indirect roles in gene regulation (for example, by acting as microRNA sponges); however, no such roles are reported for RN7SL505P[4][5][6]. **Key Points:** - RN7SL505P is a **non-functional** pseudogene of 7SL RNA, not an active gene or protein. - No role is currently established in biology, disease, or therapy for this specific pseudogene. - Listing as a target is likely incorrect or reflects a misunderstanding of nomenclature; this is not a druggable or functional protein, enzyme, or receptor[6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 505, pseudogene (RN7SL505P).